Our latest thinking

How OTC is reshaping India’s pharmaceutical market

Learn how over-the-counter (OTC) dynamics are transforming India’s pharmaceutical market through shifting consumer behavior, regulatory clarity and insights into digital commerce.

FY27 Budget outlook: Sustaining growth while negotiating global headwinds

Read about FY27 Budget Outlook for India, highlighting growth prospects with FY26 real and nominal GDP projected at 7.4% and 8.0%, fiscal consolidation targets, potential deficit reduction and expenditure priorities.

India’s data privacy shift: Steering the DPDP compliance and readiness

Discover how India’s DPDP Act and Rules are reshaping data privacy compliance, business readiness and digital trust strategies for enterprises, with insights from the EY survey.


    Explore insights and services for your C-suite role

    We know the imperatives of transformation and sustainable growth place varying demands on leaders across the C-suite, so we’ve curated our most actionable insights and relevant services for each leadership role.




    Featured press releases

    India’s Over-The-Counter drugs market set to hit ₹98,000 Crore by 2030, growing at 13% CAGR: EY Parthenon Report

    Mumbai, 27 January 2026. India’s Over-The-Counter drugs market set to hit ₹98,000 Crore by 2030, growing at 13% CAGR according to the EY Parthenon report.

    27 Jan 2026 | Mumbai, India | EY India

    India’s healthcare sector records cumulative deal value of over INR 10,000 crore in Q2 FY26: EY‑Parthenon Report

    Mumbai, 15 January 2026. India’s healthcare sector records cumulative deal value of over INR 10,000 crore in Q2 FY26 according to the EY Parthenon Report.

    15 Jan 2026 | Mumbai, India | EY India